vs
Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $289.7M, roughly 1.7× ESCO TECHNOLOGIES INC). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs 6.8%, a 3.1% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs -1.7%). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs -0.1%).
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ESE vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $289.7M | $493.8M |
| Net Profit | $28.7M | $33.7M |
| Gross Margin | 41.4% | — |
| Operating Margin | 13.2% | 9.9% |
| Net Margin | 9.9% | 6.8% |
| Revenue YoY | 17.3% | -1.7% |
| Net Profit YoY | 22.2% | 10.5% |
| EPS (diluted) | $1.11 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $289.7M | $493.8M | ||
| Q3 25 | $286.5M | $492.9M | ||
| Q2 25 | $296.3M | $468.8M | ||
| Q1 25 | $265.5M | $458.4M | ||
| Q4 24 | $247.0M | $502.4M | ||
| Q3 24 | $298.5M | $511.2M | ||
| Q2 24 | $260.8M | $504.3M | ||
| Q1 24 | $249.1M | $495.1M |
| Q4 25 | $28.7M | $33.7M | ||
| Q3 25 | $218.7M | $71.7M | ||
| Q2 25 | $26.1M | $39.3M | ||
| Q1 25 | $31.0M | $20.7M | ||
| Q4 24 | $23.5M | $30.5M | ||
| Q3 24 | $34.3M | $19.4M | ||
| Q2 24 | $29.2M | $-153.0M | ||
| Q1 24 | $23.2M | $4.0M |
| Q4 25 | 41.4% | — | ||
| Q3 25 | 45.9% | — | ||
| Q2 25 | 41.2% | — | ||
| Q1 25 | 41.1% | — | ||
| Q4 24 | 39.8% | — | ||
| Q3 24 | 40.1% | — | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 38.8% | — |
| Q4 25 | 13.2% | 9.9% | ||
| Q3 25 | 17.2% | 13.8% | ||
| Q2 25 | 11.2% | 12.8% | ||
| Q1 25 | 15.3% | 7.0% | ||
| Q4 24 | 11.4% | 7.8% | ||
| Q3 24 | 14.8% | 6.6% | ||
| Q2 24 | 14.3% | -31.3% | ||
| Q1 24 | 11.7% | 3.2% |
| Q4 25 | 9.9% | 6.8% | ||
| Q3 25 | 76.3% | 14.5% | ||
| Q2 25 | 8.8% | 8.4% | ||
| Q1 25 | 11.7% | 4.5% | ||
| Q4 24 | 9.5% | 6.1% | ||
| Q3 24 | 11.5% | 3.8% | ||
| Q2 24 | 11.2% | -30.3% | ||
| Q1 24 | 9.3% | 0.8% |
| Q4 25 | $1.11 | $0.40 | ||
| Q3 25 | $8.43 | $0.84 | ||
| Q2 25 | $1.01 | $0.46 | ||
| Q1 25 | $1.20 | $0.24 | ||
| Q4 24 | $0.91 | $0.37 | ||
| Q3 24 | $1.32 | $0.23 | ||
| Q2 24 | $1.13 | $-1.84 | ||
| Q1 24 | $0.90 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.8M | $375.2M |
| Total DebtLower is stronger | $145.5M | $570.5M |
| Stockholders' EquityBook value | $1.6B | $865.9M |
| Total Assets | $2.4B | $2.2B |
| Debt / EquityLower = less leverage | 0.09× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.8M | $375.2M | ||
| Q3 25 | $101.3M | $340.1M | ||
| Q2 25 | $78.7M | $224.7M | ||
| Q1 25 | $57.4M | $99.0M | ||
| Q4 24 | $71.3M | $229.9M | ||
| Q3 24 | $66.0M | $103.8M | ||
| Q2 24 | $63.0M | $19.4M | ||
| Q1 24 | $59.4M | $8.0M |
| Q4 25 | $145.5M | $570.5M | ||
| Q3 25 | $186.0M | $577.2M | ||
| Q2 25 | $525.0M | $583.9M | ||
| Q1 25 | $88.0M | $590.5M | ||
| Q4 24 | $112.0M | $597.1M | ||
| Q3 24 | $122.0M | — | ||
| Q2 24 | $173.0M | — | ||
| Q1 24 | $191.0M | — |
| Q4 25 | $1.6B | $865.9M | ||
| Q3 25 | $1.5B | $890.7M | ||
| Q2 25 | $1.3B | $833.8M | ||
| Q1 25 | $1.3B | $789.2M | ||
| Q4 24 | $1.2B | $764.9M | ||
| Q3 24 | $1.2B | $732.5M | ||
| Q2 24 | $1.2B | $706.5M | ||
| Q1 24 | $1.2B | $856.2M |
| Q4 25 | $2.4B | $2.2B | ||
| Q3 25 | $2.4B | $2.2B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $1.8B | $2.0B | ||
| Q4 24 | $1.8B | $2.2B | ||
| Q3 24 | $1.8B | $2.1B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.8B | $2.2B |
| Q4 25 | 0.09× | 0.66× | ||
| Q3 25 | 0.12× | 0.65× | ||
| Q2 25 | 0.40× | 0.70× | ||
| Q1 25 | 0.07× | 0.75× | ||
| Q4 24 | 0.09× | 0.78× | ||
| Q3 24 | 0.10× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.16× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.9M | $114.1M |
| Free Cash FlowOCF − Capex | $63.0M | — |
| FCF MarginFCF / Revenue | 21.7% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 2.40× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $239.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.9M | $114.1M | ||
| Q3 25 | $109.9M | $137.3M | ||
| Q2 25 | $73.7M | $137.2M | ||
| Q1 25 | $24.1M | $-117.5M | ||
| Q4 24 | $34.2M | $133.0M | ||
| Q3 24 | $72.1M | $91.8M | ||
| Q2 24 | $36.2M | $107.0M | ||
| Q1 24 | $10.5M | $-125.2M |
| Q4 25 | $63.0M | — | ||
| Q3 25 | $97.8M | — | ||
| Q2 25 | $64.9M | — | ||
| Q1 25 | $14.0M | — | ||
| Q4 24 | $29.0M | — | ||
| Q3 24 | $60.9M | — | ||
| Q2 24 | $27.6M | — | ||
| Q1 24 | $2.0M | — |
| Q4 25 | 21.7% | — | ||
| Q3 25 | 34.1% | — | ||
| Q2 25 | 21.9% | — | ||
| Q1 25 | 5.3% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | 0.8% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | 3.8% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 3.4% | — |
| Q4 25 | 2.40× | 3.39× | ||
| Q3 25 | 0.50× | 1.91× | ||
| Q2 25 | 2.83× | 3.49× | ||
| Q1 25 | 0.78× | -5.66× | ||
| Q4 24 | 1.46× | 4.36× | ||
| Q3 24 | 2.10× | 4.72× | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.45× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
